RPC Stock Analysis: Ridgepost Capital | NYSE
Asset Management | NYSE, USA | Market Cap: 959m USD | 12M Return: -28.7% | US69376K1060 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.72M
EPS Trend: 77.9%
Qual. Beats: 0
Rev. Trend: 93.5%
Warnings
Tailwinds
No distinct edge detected
Seasonality 9.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ridgepost Capital, Inc. (NYSE: RPC) is a multi-asset class private market solutions provider operating in the alternative asset management industry across the United States, North America, Europe, and other international markets. The firm offers a diversified suite of private market solutions, including private equity, venture capital, impact investing, and private credit, along with primary fund of funds, secondary investment, and direct and co-investment services. The company distributes its offerings through a multi-brand platform: private equity solutions under the RCP Advisors, Bonaccord Capital, Ridgepost Advisors, and Qualitas brands; venture capital under the TrueBridge brand; impact investing under the Enhanced brand; and private credit under the Five Points, Hark Capital, and WTI brands.
The company was founded in 1992 and is headquartered in Dallas, Texas. It was previously known as P10, Inc. and adopted the Ridgepost Capital name in February 2026. As a player in the alternative asset management sector, Ridgepost Capital generates revenue primarily through management fees and performance-based incentives (commonly known as carried interest) on assets managed across its various private market strategies. The multi-brand, multi-strategy structure is a common approach in alternative asset management, allowing each subsidiary to maintain specialized expertise and brand identity while benefiting from shared corporate infrastructure.
- Private credit AUM expands as institutional demand for yield accelerates
- Fundraising momentum and new fund vintages grow fee-earning AUM
- Exit activity and realizations drive performance fee revenue
| Net Income: 27.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.52 > 1.0 |
| NWC/Revenue: -19.28% < 20% (prev 14.38%; Δ -33.65% < -1%) |
| CFO/TA 0.05 > 3% & CFO 55.8m > Net Income 27.4m |
| Net Debt (509.8m) to EBITDA (108.7m): 4.69 < 3 |
| Current Ratio: 0.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (119.5m) vs 12m ago 0.67% < -2% |
| Gross Margin: 72.31% > 18% (prev 49.54%; Δ 22.77% > 0.5%) |
| Asset Turnover: 30.01% > 50% (prev 32.14%; Δ -2.13% > 0%) |
| Interest Coverage Ratio: 3.06 > 6 (EBIT TTM 83.0m / Interest Expense TTM 27.1m) |
| A: -0.05 (Total Current Assets 181.9m - Total Current Liabilities 242.2m) / Total Assets 1.15b |
| B: -0.16 (Retained Earnings -179.0m / Total Assets 1.15b) |
| C: 0.08 (EBIT TTM 83.0m / Avg Total Assets 1.04b) |
| D: 0.58 (Book Value of Equity 367.5m / Total Liabilities 635.8m) |
| Altman-Z'' = 0.29 = B |
| DSRI: 1.12 (Receivables 144.1m/123.5m, Revenue 312.9m/299.6m) |
| GMI: 0.69 (GM 49.54% / 72.31%) |
| AQI: 1.03 (AQ_t 0.81 / AQ_t-1 0.79) |
| SGI: 1.04 (Revenue 312.9m / 299.6m) |
| TATA: -0.02 (NI 27.4m - CFO 55.8m) / TA 1.15b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of August 23, 2026, the stock is trading at USD 8.76 with a total of 665,354 shares traded. Over the past week, the price has changed by +1.04%, over one month by -0.68%, over three months by +5.79% and over the past year by -28.70%.
Current recommended Stop Loss: 7.80 (which is 11% or 2.6 ATR below the current price).
Ridgepost Capital has no consensus analysts rating.
P/E Trailing = 36.25
P/E Forward = 8.4459
P/S = 3.0403
P/B = 2.61
Revenue TTM = 312.9m USD
EBIT TTM = 83.0m USD
EBITDA TTM = 108.7m USD
Long Term Debt = 311.7m USD (from longTermDebt, last quarter)
Short Term Debt = 179.0m USD (from shortTermDebt, last quarter)
Debt = 547.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 28.4m
Net Debt = 509.8m USD (calculated: Debt 547.5m - CCE 37.8m)
Enterprise Value = 1.47b USD (959.1m + Debt 547.5m - CCE 37.8m)
Interest Coverage Ratio = 3.06 (Ebit TTM 83.0m / Interest Expense TTM 27.1m)
EV/FCF = 27.61x (Enterprise Value 1.47b / FCF TTM 53.2m)
FCF Yield = 3.62% (FCF TTM 53.2m / Enterprise Value 1.47b)
FCF Margin = 17.00% (FCF TTM 53.2m / Revenue TTM 312.9m)
Net Margin = 8.75% (Net Income TTM 27.4m / Revenue TTM 312.9m)
Gross Margin = 72.31% ((Revenue TTM 312.9m - Cost of Revenue TTM 86.6m) / Revenue TTM)
Gross Margin QoQ = 92.18% (prev 92.13%)
Tobins Q-Ratio = 1.27 (Enterprise Value 1.47b / Total Assets 1.15b)
Interest Expense / Debt = 4.95% (Interest Expense 27.1m / Debt 547.5m)
Taxrate = 30.66% (14.3m / 46.5m)
NOPAT = 57.6m (EBIT 83.0m * (1 - 30.66%))
Current Ratio = 0.75 (Total Current Assets 181.9m / Total Current Liabilities 242.2m)
Debt / Equity = 1.49 (Debt 547.5m / totalStockholderEquity, last quarter 367.5m)
Debt / EBITDA = 4.69 (Net Debt 509.8m / EBITDA 108.7m)
Debt / FCF = 9.58 (Net Debt 509.8m / FCF TTM 53.2m)
Total Stockholder Equity = 353.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.63% (Net Income 27.4m / Total Assets 1.15b)
RoE = 7.74% (Net Income TTM 27.4m / Total Stockholder Equity 353.7m)
RoCE = 12.48% (EBIT 83.0m / Capital Employed (Equity 353.7m + L.T.Debt 311.7m))
RoIC = 5.36% (NOPAT 57.6m / Invested Capital 1.07b)
WACC = 7.49% (E(959.1m)/V(1.51b) * Re(9.80%) + D(547.5m)/V(1.51b) * Rd(4.95%) * (1-Tc(0.31)))
Discount Rate = 9.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -57.78 | Cagr: -1.21%
[DCF] Terminal Value 74.44% ; FCFF base≈54.8m ; Y1≈51.8m ; Y5≈48.6m
[DCF] Fair Price = 3.25 (EV 766.6m - Net Debt 509.8m = Equity 256.9m / Shares 79.0m; r=8.35% [WACC [floored]]; 5y FCF grow -6.99% → 2.50% )
EPS Correlation: 77.92 | EPS CAGR: 19.60% | SUE: -0.47 | # QB: 0
Revenue Correlation: 93.50 | Revenue CAGR: 10.84% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.25 | Chg30d=-9.74% | Revisions=-40% | Analysts=3
EPS current Year (2026-12-31): EPS=1.00 | Chg30d=-2.07% | Revisions=-40% | GrowthEPS=+8.8% | GrowthRev=+20.0%
EPS next Year (2027-12-31): EPS=1.16 | Chg30d=-3.45% | Revisions=-17% | GrowthEPS=+16.2% | GrowthRev=+16.8%
[Analyst] Revisions Ratio: -50% (up=1, down=6)